CHARLES D. NIEBYLSKI

PATENT ATTORNEY

Overview

CHARLES D. NIEBYLSKI, Ph.D. is a Senior Associate Attorney in the Chemical, Pharmaceutical and Biotechnology Department of The Nath Law Group.

His practice includes patent procurement, opinions on validity, infringement, and freedom to operate, and strategic client counseling. His expertise encompasses developing strategies for extending patent portfolio protection, conducting due diligence and patent landscape analysis for merger and acquisition activities, and advising on I.P. issues related to product development, importation, FDA regulation, and commercialization activities.

Prior to law school, Dr. Niebylski managed his own successful research program as a Fellow at The National Institutes of Health in Bethesda Maryland studying biophysical and biochemical mechanisms of transmembrane neuronal signaling and the ability of small molecules (e.g. ethanol, polyunsaturated lipids, drugs) to influence biological structure and activity of receptors, membrane domains, sensory pathways, and their clinical implications. The NIH Board of Scientific Counselors recognized the importance of his work, rewarding his program with additional funding and support. His contributions to science include numerous research articles, international presentations, and collaborations in the fields of biophysics, neuroscience, cell biology, immunology, cancer biology, nutrition, drug addiction research, and materials science. He has seventeen years of experience studying molecular structure and function in biological and chemical systems at laboratories in academia, government, and industry.

As a graduate student, he also served as a Research Associate at the Pathology Department of the Detroit Medical Center developing novel clinical cancer DNA diagnostic tests, and received honors for his success in teaching biology to undergraduate nonscience majors. As an undergraduate he conducted chemical analysis of atomic-surface catalysis and novel amorphous materials at the University of California’s Lawrence Berkeley Laboratory, at Energy Conversion Devices, in Troy, Michigan, and at the University of Notre Dame, School of Engineering.

Dr. Niebylski earned his J.D. from Catholic University, Columbus School of Law, Washington, D.C., in 2000. In 1990 and 1987, he received his Ph.D. and M.S. degrees in Biophysics, Minor in Immunology, from Wayne State University in Detroit, for his work on biophysical mechanisms of lymphocyte Fc-receptor-mediated immune activation and immunosuppression induced by cyclosporine. Dr. Niebylski was then honored with a National Research Council Fellowship Award in 1991 to start-up a section of biophysical studies for collaborative research in neurobiology and analytical biochemistry at The National Institutes of Health in Bethesda Maryland. Dr. Niebylski graduated with a Bachelor of Science degree from the University of Notre Dame in 1982.

Dr. Niebylski is registered to practice before the United States Patent and Trademark Office, and admitted to practice before the Bars of the District of Columbia and the State of Maryland. He is a member of the American Intellectual Property Association.